{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:11:03Z","timestamp":1784574663411,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Capital's Funds for Health Improvement and Research","award":["2020-2-4033, 2020-4-4035"],"award-info":[{"award-number":["2020-2-4033, 2020-4-4035"]}]},{"name":"the Capital's Funds for Health Improvement and Research","award":["2020-2-4033, 2020-4-4035"],"award-info":[{"award-number":["2020-2-4033, 2020-4-4035"]}]},{"name":"Beijing Municipal Science and Technology Project","award":["Z181100001718200"],"award-info":[{"award-number":["Z181100001718200"]}]},{"name":"the Youth Fund of Zhongshan Hospital, Fudan University","award":["2021-016"],"award-info":[{"award-number":["2021-016"]}]},{"name":"the Yangfan Project of Science and Technology Commission of Shanghai Municipality","award":["22YF1439500"],"award-info":[{"award-number":["22YF1439500"]}]},{"name":"Beijing Municipal Natural Science Foundation","award":["7202168"],"award-info":[{"award-number":["7202168"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2020-I2M-C&T-B-055, 2021-I2M-C&T-B-032"],"award-info":[{"award-number":["2020-I2M-C&T-B-055, 2021-I2M-C&T-B-032"]}]},{"name":"\u201cDouble First-Class\u201d Discipline Construction Fund of Peking Union Medical College and Chinese Academy of Medical Sciences","award":["2019E-XK04-02"],"award-info":[{"award-number":["2019E-XK04-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cystatin C is a novel biomarker to identify renal dysfunction and cardiovascular risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The aim of this study was to investigate the role of cystatin C in non-invasive risk prediction in a large cohort of patients with pre-capillary pulmonary hypertension (PH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We retrospectively analyzed pre-capillary PH patients with available cystatin C and hemodynamic data derived from right heart catheterization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 398 consecutive patients with confirmed pre-capillary PH were recruited from Fuwai Hospital between November 2020 and November 2021. Over a median duration of 282\u00a0days, 72 (18.1%) of these patients experienced clinical worsening. Cystatin C levels significantly correlated with cardiac index (<jats:italic>r<\/jats:italic>\u2009=\u2009-0.286, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), mixed venous oxygen saturation (<jats:italic>r<\/jats:italic>\u2009=\u2009-0.216, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and tricuspid annular plane systolic excursion (<jats:italic>r<\/jats:italic>\u2009=\u2009-0.236, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and high cystatin C levels independently predicted a poor prognosis after adjusting potential confounders in different models (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). A three-group non-invasive risk model was constructed based on the combined assessment of the cystatin C and WHO-FC using dichotomous cut-off value. Those patients with higher cystatin C (\u2265\u20091.0\u00a0mg\/L) and a worse WHO-FC experienced the highest risk of endpoint occurrence. The predictive capacity of this model was comparable to that of an existing invasive risk stratification model (area under curve: 0.657 vs 0.643, <jats:italic>P<\/jats:italic>\u2009=\u20090.619).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Cystatin C levels were associated with disease severity and prognosis in patients with pre-capillary PH. A combination of high cystatin C and advanced WHO-FC identifies patients at particularly high risk of clinical deterioration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02595-1","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T08:02:58Z","timestamp":1693036978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The potential of cystatin C as a predictive biomarker in pulmonary hypertension"],"prefix":"10.1186","volume":"23","author":[{"given":"Anqi","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"issue":"1","key":"2595_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12890-023-02425-4","volume":"23","author":"H Ni","year":"2023","unstructured":"Ni H, Wei Y, Yang L, Wang Q. An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis. BMC Pulm Med. 2023;23(1):221. https:\/\/doi.org\/10.1186\/s12890-023-02425-4. Published 2023 Jun 21.","journal-title":"BMC Pulm Med"},{"issue":"8","key":"2595_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/medicina58081094","volume":"58","author":"B Ruaro","year":"2022","unstructured":"Ruaro B, Confalonieri P, Caforio G, et al. Chronic thromboembolic pulmonary hypertension: an observational study. Medicina (Kaunas). 2022;58(8):1094. https:\/\/doi.org\/10.3390\/medicina58081094. Published 2022 Aug 13.","journal-title":"Medicina (Kaunas)"},{"issue":"38","key":"2595_CR3","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension [published correction appears in Eur Heart J. 2023 Apr 17;44(15):1312]. Eur Heart J. 2022;43(38):3618\u2013731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237.","journal-title":"Eur Heart J"},{"key":"2595_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ijcard.2016.02.003","volume":"209","author":"IM Blok","year":"2016","unstructured":"Blok IM, van Riel AC, Schuuring MJ, et al. The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease. Int J Cardiol. 2016;209:242\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.003.","journal-title":"Int J Cardiol"},{"key":"2595_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/resp.12259","volume":"19","author":"BE Fenster","year":"2014","unstructured":"Fenster BE, Lasalvia L, Schroeder JD, et al. Cystatin C: a potential biomarker for pulmonary arterial hypertension. Respirology. 2014;19:583\u20139. https:\/\/doi.org\/10.1111\/resp.12259.","journal-title":"Respirology"},{"key":"2595_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/joim.12131","volume":"275","author":"R Kaiser","year":"2014","unstructured":"Kaiser R, Seiler S, Held M, et al. Prognostic impact of renal function in precapillary pulmonary hypertension. J Intern Med. 2014;275:116\u201326. https:\/\/doi.org\/10.1111\/joim.12131.","journal-title":"J Intern Med"},{"key":"2595_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-023-04487-y","author":"C Sahin","year":"2023","unstructured":"Sahin C, Pamukcu O. Serum Cystatin C: a potential biomarker in pulmonary hypertension in children. Indian J Pediatr. 2023. https:\/\/doi.org\/10.1007\/s12098-023-04487-y.","journal-title":"Indian J Pediatr"},{"key":"2595_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/circulationaha.116.022362","volume":"141","author":"S Rosenkranz","year":"2020","unstructured":"Rosenkranz S, Howard LS, Gomberg-Maitland M, et al. Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation. 2020;141:678\u201393. https:\/\/doi.org\/10.1161\/circulationaha.116.022362.","journal-title":"Circulation"},{"key":"2595_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"2595_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1114248.","journal-title":"N Engl J Med"},{"key":"2595_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2020.04.044","volume":"80","author":"LX Zou","year":"2020","unstructured":"Zou LX, Sun L, Nicholas SB, et al. Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation. Eur J Intern Med. 2020;80:29\u201334. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.044.","journal-title":"Eur J Intern Med"},{"key":"2595_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2016.05.092","volume":"68","author":"SW van der Laan","year":"2016","unstructured":"van der Laan SW, Fall T, Soumar\u00e9 A, et al. Cystatin C and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2016;68:934\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.092.","journal-title":"J Am Coll Cardiol"},{"key":"2595_CR13","doi-asserted-by":"publisher","first-page":"e020745","DOI":"10.1161\/jaha.121.020745","volume":"11","author":"M West","year":"2022","unstructured":"West M, Kirby A, Stewart RA, et al. Circulating cystatin C is an independent risk marker for cardiovascular outcomes, development of renal impairment, and long-term mortality in patients with stable coronary heart disease: the LIPID study. J Am Heart Assoc. 2022;11:e020745. https:\/\/doi.org\/10.1161\/jaha.121.020745.","journal-title":"J Am Heart Assoc"},{"key":"2595_CR14","doi-asserted-by":"publisher","first-page":"204062232211028","DOI":"10.1177\/20406223221102803","volume":"13","author":"A Duan","year":"2022","unstructured":"Duan A, Li X, Jin Q, et al. Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension. Ther Adv Chronic Dis. 2022;13:20406223221102804. https:\/\/doi.org\/10.1177\/20406223221102803.","journal-title":"Ther Adv Chronic Dis"},{"key":"2595_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/heartjnl-2015-307786","volume":"102","author":"P Callan","year":"2016","unstructured":"Callan P, Clark AL. Right heart catheterisation: indications and interpretation. Heart. 2016;102:147\u201357. https:\/\/doi.org\/10.1136\/heartjnl-2015-307786.","journal-title":"Heart"},{"key":"2595_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"2595_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341. https:\/\/doi.org\/10.1159\/000180580.","journal-title":"Nephron"},{"key":"2595_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"key":"2595_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903\u201375. https:\/\/doi.org\/10.1183\/13993003.01032-2015.","journal-title":"Eur Respir J"},{"key":"2595_CR20","doi-asserted-by":"publisher","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","volume":"50","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50:1700740. https:\/\/doi.org\/10.1183\/13993003.00740-2017.","journal-title":"Eur Respir J"},{"key":"2595_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.healun.2017.10.028","volume":"37","author":"MM Chakinala","year":"2018","unstructured":"Chakinala MM, Coyne DW, Benza RL, et al. Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis. J Heart Lung Transplant. 2018;37:696\u2013705. https:\/\/doi.org\/10.1016\/j.healun.2017.10.028.","journal-title":"J Heart Lung Transplant"},{"key":"2595_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/690018","volume":"7","author":"NP Nickel","year":"2017","unstructured":"Nickel NP, O\u2019Leary JM, Brittain EL, et al. Kidney dysfunction in patients with pulmonary arterial hypertension. Pulm Circ. 2017;7:38\u201354. https:\/\/doi.org\/10.1086\/690018.","journal-title":"Pulm Circ"},{"issue":"5","key":"2595_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2215\/CJN.10191013","volume":"9","author":"SD Navaneethan","year":"2014","unstructured":"Navaneethan SD, Wehbe E, Heresi GA, et al. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014;9(5):855\u201363. https:\/\/doi.org\/10.2215\/CJN.10191013.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2595_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","volume":"9","author":"K Damman","year":"2007","unstructured":"Damman K, Navis G, Smilde TD, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9(9):872\u20138. https:\/\/doi.org\/10.1016\/j.ejheart.2007.05.010.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2595_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2047487319870344","volume":"27","author":"A Aimo","year":"2020","unstructured":"Aimo A, Castiglione V, Borrelli C, et al. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020;27(5):494\u2013510. https:\/\/doi.org\/10.1177\/2047487319870344.","journal-title":"Eur J Prev Cardiol"},{"key":"2595_CR26","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ki.2008.516","volume":"111","author":"V Cachofeiro","year":"2008","unstructured":"Cachofeiro V, Goicochea M, de Vinuesa SG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;111:S4-9. https:\/\/doi.org\/10.1038\/ki.2008.516.","journal-title":"Kidney Int Suppl"},{"key":"2595_CR27","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.3390\/jcm11237136","volume":"11","author":"M Toma","year":"2022","unstructured":"Toma M, Miceli R, Bonsante E, et al. Left Heart disease phenotype in elderly patients with pulmonary arterial hypertension: insights from the Italian PATRIARCA registry. J Clin Med. 2022;11:7136. https:\/\/doi.org\/10.3390\/jcm11237136.","journal-title":"J Clin Med"},{"key":"2595_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2019.10.025","volume":"72","author":"K Kashani","year":"2020","unstructured":"Kashani K, Rosner MH, Ostermann M. Creatinine: from physiology to clinical application. Eur J Intern Med. 2020;72:9\u201314. https:\/\/doi.org\/10.1016\/j.ejim.2019.10.025.","journal-title":"Eur J Intern Med"},{"key":"2595_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000487198","volume":"47","author":"L Bitker","year":"2018","unstructured":"Bitker L, Sens F, Payet C, et al. Presence of kidney disease as an outcome predictor in patients with pulmonary arterial hypertension. Am J Nephrol. 2018;47:134\u201343. https:\/\/doi.org\/10.1159\/000487198.","journal-title":"Am J Nephrol"},{"key":"2595_CR30","doi-asserted-by":"publisher","first-page":"e003940","DOI":"10.1161\/circheartfailure.116.003940","volume":"10","author":"S Selvaraj","year":"2017","unstructured":"Selvaraj S, Shah SJ, Ommerborn MJ, et al. Pulmonary hypertension is associated with a higher risk of heart failure hospitalization and mortality in patients with chronic kidney disease: the Jackson heart study. Circ Heart Fail. 2017;10:e003940. https:\/\/doi.org\/10.1161\/circheartfailure.116.003940.","journal-title":"Circ Heart Fail"},{"key":"2595_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jchf.2015.03.007","volume":"3","author":"EA Secemsky","year":"2015","unstructured":"Secemsky EA, Scherzer R, Nitta E, et al. Novel biomarkers of cardiac stress, cardiovascular dysfunction, and outcomes in HIV-infected individuals. JACC Heart Fail. 2015;3:591\u20139. https:\/\/doi.org\/10.1016\/j.jchf.2015.03.007.","journal-title":"JACC Heart Fail"},{"key":"2595_CR32","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/ar3759","volume":"14","author":"JT Gustafsson","year":"2012","unstructured":"Gustafsson JT, Simard JF, Gunnarsson I, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther. 2012;14:R46. https:\/\/doi.org\/10.1186\/ar3759.","journal-title":"Arthritis Res Ther"},{"key":"2595_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.clinbiochem.2017.07.016","volume":"50","author":"T Breidthardt","year":"2017","unstructured":"Breidthardt T, Sabti Z, Ziller R, et al. Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem. 2017;50:1007\u201313. https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.07.016.","journal-title":"Clin Biochem"},{"key":"2595_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cardfail.2020.07.013","volume":"27","author":"JB Ivey-Miranda","year":"2021","unstructured":"Ivey-Miranda JB, Inker LA, Griffin M, et al. Cystatin C and muscle mass in patients with heart failure. J Card Fail. 2021;27:48\u201356. https:\/\/doi.org\/10.1016\/j.cardfail.2020.07.013.","journal-title":"J Card Fail"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02595-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T13:10:22Z","timestamp":1700313022000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2595"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02595-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and the protocol was reviewed by the Ethics Committee of Fuwai hospital [Approval number: 2020\u20131364], with written informed consent obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}